GOF mutations are characterized by a loss of sequence-specific DNA binding and they revert the p53 function from tumor suppressor to oncogene [70], ultimately promoting cell transformation, tumor progression, metastasis, and chemoresistance. The gene discussed is TP53; the disease is neoplasm.